Graft-Versus-Host Disease (GvHD)


Washington University Conducts Trial to Assess Breakthrough Stem Cell Production Technology

The FDA has given the green light to a first-ever clinical trial to assess the ApoGraft technology for haploidentical bone marrow transplantations to be conducted at Washington University School of Medicine in St. Louis. Sponsor is Cellect Biotechnology Ltd., (NASDAQ:...

Pin It on Pinterest